Stock·NASDAQ·Technology
Arm Holdings (ARM)
- Market cap
- $243.29B
- P/E
- 234.85
- Dividend yield
- 0.00%
- Street target
- $278.60median of 43 analysts
- 52-week range
- $100.02 $452.70
The short version
Where ARM stands today, in four lines, and what CleaRank Financial AI makes of it.
ARM at a glance
Arm Holdings (ARM): Hold, 48/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($223.44 and $267.88).
- Earnings ARM beat estimates in 5 of its last 6 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $72.2M and made no open-market purchases over the last 18 months.
- Valuation P/E of 234.8 against 35.1 for the Technology sector: a premium to peers (+569%).
Figures as of October 17, 2026.
CleaRank Financial AI
Arm Holdings (ARM) earns a Hold rating from CleaRank, with a model score of 48/100.
The biggest lift comes from the analysts' outlook, where 29 of 43 analysts recommend buying and the median target is 22.3% above the price. The largest drag is valuation: ARM's P/E of 234.85 is 569.1% above the sector median P/E (a premium to peers), and its P/S of 47.19 is 520.9% above the sector median P/S. Trend signals are mixed, since the price is 14.96% below its 50-day average of $267.88 yet 1.95% above its 200-day average of $223.44. Across the past year the price gained 33.07%.
Only on CleaRank
Figures we compute ourselves from ARM's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $227.80 is 15.0% below the 50-day simple moving average of $267.88.Price above its 200-day average ›
The price is 1.9% above the 200-day simple moving average of $223.44.50-day average above the 200-day ›
The 50-day average ($267.88) is 19.9% above the 200-day average ($223.44), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 36% of its 52-week range, between $100.02 and $452.70.
ARM share price
Pick a period: each tab shows how far ARM has moved over it, to the last close.
Today's trading
Where ARM sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 234.85 is 569.1% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 47.19 is 520.9% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $1.0B on revenue of $5.2B, a net margin of 20.2%.Beat estimates in most recent reports ›
ARM beat the EPS estimate in 5 of its last 6 reports.
Key statistics
The headline figures for ARM.
As of October 17, 2026, ARM trades at $227.80, with a market value of $243.29B and a P/E ratio of 234.85.
What the numbers say
CleaRank Financial AI's reading of ARM's valuation, growth and risks.
ARM's P/E of 234.85 is 569.1% above the 35.1 median P/E of Technology stocks, which means the P/E is a premium to peers. Arm Holdings (ARM) also trades at a price-to-sales ratio of 47.19, which is 520.9% above the sector median of 7.6. The company has a market capitalisation of $243.3B and trailing earnings of $0.97 per share.
ARM is growing more slowly than its sector. Revenue rose 22.40% in the latest year, while the sector median is 24.2%. The company converts sales into a 20.25% net margin and a 7.60% operating margin. Return on equity, a measure of how well shareholders' capital is used, comes in at 13.35%, which is below the sector median of 13.4%. Debt-to-equity stands at 0.06.
Arm Holdings (ARM)'s most recent available report in our data, dated May 6, 2026, showed EPS of $0.6. The figure beat the analysts' estimate by 3.45%, but the share price still dropped 10.11% in the following session.
ARM beat the EPS estimate in 5 of its last 6 reports, but beats have not guaranteed gains: the stock fell the next day after 3 of them. The largest of the earlier reactions came after the July 30, 2025 report, which missed the estimate by 0.00% while the stock fell 13.44%.
ARM's daily returns have a 30-day standard deviation of 5.58%. With a P/E of 234.85 that is 569.1% above the sector median, the stock is priced as a premium to peers, so any weaker results would face a higher bar. The price sits 49.68% below its 52-week high of $452.70. Over the last 18 months insiders sold $72.2M of stock and bought none on the open market. Sales like these are often planned ahead or made to cover taxes on vesting shares, so they tell less than purchases would.
ARM against the Technology sector
How ARM compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: ARM trades at a significant premium to sector peers (+569%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, ARM has gained 86.1% against a gain of 71.7% for XLK.
Performance against XLK
ARM and the Technology sector fund over the same days.
Revenue and earnings
How much ARM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.8% in FY2026 to $4.9B, from $4.0B a year earlier.
Profit margin: The net margin was 18.4% in FY2026, down from 19.8% the year before.
Profitable: ARM earned $904M in FY2026.
Earnings reality check
Did ARM beat what analysts expected, and how did the stock react?
Earnings record: ARM beat the analyst estimate in 5 of the last 6 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| May 6, 2026after close | $0.58 | $0.60 | +3.45% | -10.11% | -6.78% |
| Feb 4, 2026after close | $0.41 | $0.43 | +4.88% | +5.70% | +19.43% |
| Jul 30, 2025after close | $0.35 | $0.35 | +0.00% | -13.44% | -16.66% |
| May 7, 2025after close | $0.52 | $0.55 | +5.77% | -6.18% | +7.46% |
| Feb 5, 2025after close | $0.34 | $0.39 | +14.71% | -3.34% | -10.30% |
| Nov 6, 2024after close | $0.26 | $0.30 | +15.38% | +4.13% | -6.63% |
Reports after May 6, 2026 are not yet in our data.
As of October 17, 2026, ARM has beaten the analyst EPS estimate in 5 of its last 6 reported quarters and fell in the first trading session after 3 of those beats; its most recent report in our data, on May 6, 2026, came in 3.45% above the estimate and the stock moved -10.11% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 34.5, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 34.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of ARM
The score, the reasoning behind it, and what could move the price next.
Arm Holdings (ARM) is giving a mixed trend reading. The price of $227.80 sits 14.96% below its 50-day average of $267.88, yet it is 1.95% above its 200-day average of $223.44. The 50-day average is 19.89% above the 200-day one, so the longer averages have not yet adjusted to the weaker recent price. Over the past year, the price is 127.75% above the 52-week low of $100.02 and 49.68% below the 52-week high of $452.70.
The recent dip sits within a longer record that is still firmer. Over the past month the price slid 6.63%, and over the past three months it dropped 14.74%, yet across the past year it climbed 33.07%. Momentum leans weak: the 14-day RSI at 34.5 sits in the bearish zone without reaching oversold territory, and the MACD line is negative.
Earnings beat ›
The May 6, 2026 report beat the EPS estimate by 3.45%, and the share price fell 10.11% in the first session after it.
Source: Earnings report, May 6, 2026
Rating reaffirmed ›
Rosenblatt kept its Buy rating on July 31, 2026.
Source: Analyst action, Rosenblatt, July 31, 2026
- The two nearest levels to watch are the 50-day SMA at $267.88, which sits above the price, and the 200-day SMA at $223.44, which sits below it.
- With the 14-day RSI at 34.5, momentum reads as bearish but not oversold, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- The share price fell 10.11% in the first session after the May 6, 2026 report. ARM has beaten estimates in 5 of the last 6 reports.
ARM's trend is split. The price is above its 200-day average of $223.44 but under its 50-day average of $267.88. Closing above the 50-day would bring both averages into an upward signal, while closing below the 200-day would bring both into a downward one. For now the nearest floor is the 200-day SMA at $223.44, and the nearest ceiling is the 50-day SMA at $267.88.
With the RSI in the bearish zone, momentum still leans toward further downside for ARM.
Technical indicators
Momentum and trend for ARM, from its daily closes.
As of October 17, 2026, with ARM at $227.80, its 14-day RSI is 34.5 (showing bearish momentum without being oversold), its 50-day simple moving average is $267.88 and its 200-day is $223.44.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ARM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, ARM's 1-year correlation of daily returns is +0.60 with S&P 500 (SPY), +0.68 with Nasdaq 100 (QQQ), +0.23 with Bitcoin (BTC) and +0.15 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
29 of 43 analysts rate it a buy or strong buy, 12 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $278.60 is 22.3% above the price.More buy ratings than three months ago ›
29 of 43 rate it a buy now, against 27 of 40 three months ago.
ARM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 31, 2026 | Rosenblatt | Maintains | Buy |
| Jul 30, 2026 | UBS | Maintains | Buy |
| Jul 30, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Jul 30, 2026 | RBC Capital | Maintains | Outperform |
| Jul 30, 2026 | TD Cowen | Maintains | Buy |
| Jul 30, 2026 | Wells Fargo | Maintains | Overweight |
As of October 17, 2026, 43 Wall Street analysts cover ARM: 29 rate it a buy or strong buy, 12 a hold and 2 a sell or strong sell. Their 12-month price targets range from $125.00 to $500.00, with a median of $278.60, 22.3% above the price of $227.80.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ARM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
ARM moves about 5.6% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ARM tends to move, against the market and on its own.
The long record
ARM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 5.58% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 54.0%, from July 2024 to April 2025, regained by April 2026.Most 1-year holds ended higher ›
73% of 1-year holding periods in the last 3 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in September 2023 is now worth $35,823, against $17,633 in the S&P 500 (SPY).
ARM Drawdowns & Recovery
As of October 17, 2026, ARM's worst peak-to-trough fall over the last 3 years with dividends reinvested was -54.0% (July 2024 to April 2025); it regained that peak by April 2026, 12 months after the low, and 73% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ARM in September 2023 is worth now, against the same amount in the S&P 500.
Against the market: ARM beat the S&P 500 over this period: $35,823 against $17,633.
A $10,000 investment in ARM in September 2023 would be worth about $35,823 today with dividends reinvested, compared with about $17,633 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ARM, and which have not.
Strongest month, February: an average of +34.35%, up in 2 of 3 years.
Weakest month, July: an average of -17.70%, up in 0 of 3 years.
This month, October: has averaged +2.26%, up in 1 of 3 years. Past seasonality does not repeat on schedule.
Over the last 3 years, ARM's strongest calendar month has been February (average +34.35%, up in 2 of 3 years) and its weakest July (average -17.70%, up in 0 of 3 years).
Average return for each calendar month over the last 3 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ARM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ARM today could grow to about $29,885 by 2036 in the base case, with a 90th-percentile outcome near $226,727 and a 10th-percentile outcome around $3,939. Projections are statistical simulations, not guarantees.
ARM Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $353 for ARM by 2030 in the base case, from $228 today (1.5x over 4 years). The 10th-percentile path ends near $97.98. These are outcomes of a Monte Carlo simulation run on ARM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $134 | $254 | $482 | |
| 2028 | $115 | $284 | $702 | |
| 2029 | $104 | $316 | $960 | |
| 2030 | $97.98 | $353 | $1,272 | |
| 2031 | $93.97 | $394 | $1,650 |
Method: a lognormal simulation of ARM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ARM is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
ARM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought ARM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, ARM insiders reported 19 open-market sales worth $72.2M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 10.4K | $3.1M |
| Aug 31, 2026 | Rene A Haas
Chief Executive Officer
|
Grant | 64 | $15.5K |
| Aug 27, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 10.4K | $2.7M |
| Aug 17, 2026 | Laura Kathleen Bartels
Officer
|
Grant | 1.7K | - |
| Aug 7, 2026 | Jeffrey A. Sine
Director
|
Grant | 9.6K | - |
| Jun 2, 2026 | Laura Kathleen Bartels
Officer
|
Sell | 11.3K | $4.4M |
| Jun 1, 2026 | William Abbey
Officer
|
Sell | 6.6K | $2.6M |
| May 28, 2026 | William Abbey
Officer
|
Sell | 4.2K | $1.4M |
| May 22, 2026 | William Abbey
Officer
|
Sell | 2.3K | $703.4K |
| May 21, 2026 | Charlotte Claire Eaton
Officer
|
Sell | 7.8K | $2.3M |
| May 21, 2026 | Charlotte Claire Eaton
Officer
|
Sell | 7.1K | $1.9M |
| May 21, 2026 | William Abbey
Officer
|
Sell | 4.7K | $1.3M |
| May 20, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 31.9K | $7.2M |
| May 20, 2026 | William Abbey
Officer
|
Sell | 16.0K | $3.7M |
| May 19, 2026 | Spencer Collins
Officer
|
Sell | 40.9K | $8.8M |
| May 18, 2026 | Richard Roy Grisenthwaite
Officer
|
Sell | 24.3K | $5.1M |
| May 15, 2026 | William Abbey
Officer
|
Sell | 10.2K | $2.2M |
| May 15, 2026 | William Abbey
Officer
|
Grant | 23.3K | - |
| May 15, 2026 | William Abbey
Officer
|
Grant | 8.2K | - |
| May 15, 2026 | Laura Kathleen Bartels
Officer
|
Grant | 6.8K | - |
| May 15, 2026 | Jason E Child
Chief Financial Officer
|
Grant | 81.4K | - |
| May 15, 2026 | Jason E Child
Chief Financial Officer
|
Grant | 9.3K | - |
| May 15, 2026 | Spencer Collins
Officer
|
Grant | 69.1K | - |
| May 15, 2026 | Spencer Collins
Officer
|
Grant | 8.1K | - |
| May 15, 2026 | Charlotte Claire Eaton
Officer
|
Grant | 5.6K | - |
| May 15, 2026 | Charlotte Claire Eaton
Officer
|
Grant | 2.2K | - |
| May 15, 2026 | Richard Roy Grisenthwaite
Officer
|
Grant | 22.6K | - |
| May 15, 2026 | Richard Roy Grisenthwaite
Officer
|
Grant | 22.7K | - |
| May 15, 2026 | Rene A Haas
Chief Executive Officer
|
Grant | 265.6K | - |
| May 15, 2026 | Paul E Jacobs
Director
|
Grant | 2.1K | - |
| May 15, 2026 | Rosemary M Schooler
Director
|
Grant | 2.1K | - |
| May 15, 2026 | Jeffrey A. Sine
Director
|
Grant | 2.1K | - |
| May 15, 2026 | Young K Sohn
Director
|
Grant | 2.1K | - |
| May 11, 2026 | Spencer Collins
Officer
|
Sell | 52.0K | $11.0M |
| Apr 22, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 21.3K | $3.8M |
| Apr 14, 2026 | Rene A Haas
Chief Executive Officer
|
Sell | 9.3K | $1.5M |
| Mar 26, 2026 | Rene A Haas
Chief Executive Officer
|
Sell | 31.9K | $5.1M |
| Mar 25, 2026 | Jason E Child
Chief Financial Officer
|
Sell | 21.3K | $3.2M |
Source: TwelveData, from reported insider filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.